Pulse Biosciences Profit Margin 2016-2019 | PLSE
Current and historical gross margin, operating margin and net profit margin for Pulse Biosciences (PLSE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pulse Biosciences net profit margin as of March 31, 2019 is 0%.
|Pulse Biosciences Annual Profit Margins
|Pulse Biosciences Quarterly Profit Margins
||Medical Instruments Manufacturing
Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.